By combining advances in polyurethane material technology and manufacturing processes, BD offers a family of smaller-diameter* Modified Seldinger Technique (MST) midlines that maintain high performance for infusion therapy.
By combining advances in polyurethane material technology and manufacturing processes, BD offers a family of smaller-diameter* Modified Seldinger Technique (MST) midlines that maintain high performance for infusion therapy.
GTIN - each
00801741154140
1
GTIN - Case
10801741154147
3
Packaged with
Max Barrier with BioPatch™ Dressing
Quantity
3/case
Average Gravity Flow Rate
1,298 mL/hr
Average Priming Volume
0.35 mL
Catheter Length
20 cm
Catheter Type
4 Fr dual lumen
Lumen Size
18/18
Maximum Achievable Pump Flow Rate
Saline (1.0 cP): >999.99 mL/hr, TPN (2.0 cP): >999.99mL/hr, Blood (3.5 cP): 832 mL/hr
Power Injection Flow Rate
6 mL/sec
GTIN - each | 00801741154140 | 1 |
GTIN - Case | 10801741154147 | 3 |
Packaged with | Max Barrier with BioPatch™ Dressing |
Quantity | 3/case |
Average Gravity Flow Rate | 1,298 mL/hr |
Average Priming Volume | 0.35 mL |
Catheter Length | 20 cm |
Catheter Type | 4 Fr dual lumen |
Lumen Size | 18/18 |
Maximum Achievable Pump Flow Rate | Saline (1.0 cP): >999.99 mL/hr, TPN (2.0 cP): >999.99mL/hr, Blood (3.5 cP): 832 mL/hr |
Power Injection Flow Rate | 6 mL/sec |
BD offers training resources to help improve your clinical practices as part of our goal of advancing the world of health.
BD supports the healthcare industry with market-leading products and services that aim to improve care while lowering costs. We host and take part in events that excel in advancing the world of health™.
BD promotes clinical excellence by providing various resources on best practices, clinical innovations and industry trends in healthcare.
If you are a patient or end user, you can contact us yourself, or you may have your caregiver or your physician do that for you. To help us process your
information quickly and effectively, please contact our customer complaints
team.
To better facilitate our investigation, please include the following information in your reporting: